Clinical Trials in Minneapolis

Showing 4141-4160 of 14,456 trials

Remote Trial - Tobacco Product Standard (VLNC)

NCT06442384

The goal of this pilot project is to explore the feasibility of a real-world marketplace study design examining the effects of a reduced nicotine product standard for cigarettes on smoking in the context of a flavor restriction vs. no restriction on e-cigarettes in smokers switched to very low nicotine content cigarettes.

Tobacco Use

Masonic Cancer Center, University of Minnesota11 participantsStarted Sep 2024

Minneapolis, Minnesota, United States

RECRUITINGPhase 1< 1 mile

A Study of ADRX-0405 in Subjects With Select Advanced Solid Tumors

NCT06710379

The primary purpose of this study is to assess the safety, tolerability, and pharmacokinetics, and to identify the optimal dose of ADRX-0405 in patients with select advanced solid tumors.

Solid Tumors

Adcentrx Therapeutics68 participantsStarted Dec 2024

Duarte, California, United States • Santa Monica, California, United States • Grand Rapids, Michigan, United States +5 more locations

COMPLETEDNA< 1 mile

Feasibility and Efficacy of A Remote Tai Chi Program in Older Adults

NCT06918678

This project is designed to explore the feasibility and preliminary efficacy of a remote Tai Chi program on older adults' 24-hour movement behaviors (i.e., physical activity, sedentary behavior and sleep patterns).

Aging

The University of Tennessee, Knoxville35 participantsStarted Mar 2023

Minneapolis, Minnesota, United States

Remote Trial - Tobacco Product Standard (VLNC)

A Study of ADRX-0405 in Subjects With Select Advanced Solid Tumors

Feasibility and Efficacy of A Remote Tai Chi Program in Older Adults

Find Trials by Condition in Minneapolis

AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke

AB-1002 in Patients With Class III Heart Failure

REGN2810 in Pediatric Patients With Relapsed, Refractory Solid, or Central Nervous System (CNS) Tumors and Safety and Efficacy of REGN2810 in Combination With Radiotherapy in Pediatric Patients With Newly Diagnosed or Recurrent Glioma

Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma

Comparing Ankle Fusion to Ankle Replacement

Study of ASTX295 in Patients With Solid Tumors With Wild-Type p53

CAPITAL DOREMI 2: Inotrope Versus Placebo Therapy for Cardiogenic Shock

Tezepelumab Efficacy and Safety in Reducing Oral Corticosteroid Use in Adults With Oral Corticosteroid Dependent Asthma

Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD

A Randomized, Controlled Trial to Evaluate the Safety and Effectiveness of the Route 92 Medical Reperfusion System (SUMMIT MAX)

Long-term Follow-up of Subjects With Transfusion-Dependent β-Thalassemia (TDT) Treated With Ex Vivo Gene Therapy

Study of Efficacy of CML-CP Patients Treated With ABL001 Versus Bosutinib, Previously Treated With 2 or More TKIs

Study of Elenestinib (BLU-263) in Advanced Systemic Mastocytosis (AdvSM) and and Other KIT Altered Hematologic Malignancies

Efficacy and Safety of Delgocitinib Cream in Adults With Moderate to Severe Chronic Hand Eczema (DELTA 2)

Long Term Follow-up of HPV Vaccine in HIV (CTN 236)

Study of the Adverse Events and Change in Disease State of Pediatric Participants (and Young Adults Between the Ages of 18-25) With Relapsed/Refractory Aggressive Mature B-cell Neoplasms Receiving Subcutaneous (SC) Injections of Epcoritamab

A Study of BMS-986416 With and Without Nivolumab in Select Solid Tumors